Epsilon M&A Deal Report - Galderma Pharma
Transaction Multiples for the Valuation of Private Companies
Nestlé / Galderma Pharma
No EMAT :
71541
Announced Date :
11/02/2014
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Nestlé
Target :
Galderma Pharma
Country :
Switzerland
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
Founded in 1981, Galderma discovers, develops, and markets prescription, self-medication, and aesthetic and corrective medical dermatological solutions for patients and physicians worldwide. >...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
||||
| Current |
Rating :
***
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 129
| Date | Acquirer | Target | Country | Multiples | See details |
| 14/05/2014 | Cryo-Save Group (Now Esperite) | Salveo Biotechnology Swiss Laboratory | Switzerland | ** | 71488 |
| 12/05/2010 | VITA 34 International | Novel Pharma SL (Secuvita) | Spain | * | 71420 |
Source: Epsilon Research / EMAT
